KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) EBITDA (2016 - 2025)

Historic EBITDA for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $21.3 million.

  • Dynavax Technologies' EBITDA rose 11098.0% to $21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year increase of 19506.38%. This contributed to the annual value of -$4.1 million for FY2024, which is 8886.79% up from last year.
  • As of Q3 2025, Dynavax Technologies' EBITDA stood at $21.3 million, which was up 11098.0% from $14.4 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year EBITDA high stood at $128.2 million for Q2 2022, and its period low was -$30.2 million during Q1 2023.
  • Moreover, its 5-year median value for EBITDA was $10.1 million (2024), whereas its average is $20.5 million.
  • Its EBITDA has fluctuated over the past 5 years, first skyrocketed by 129802.66% in 2022, then tumbled by 19832.59% in 2023.
  • Quarter analysis of 5 years shows Dynavax Technologies' EBITDA stood at $80.7 million in 2021, then fell by 21.78% to $63.1 million in 2022, then plummeted by 113.45% to -$8.5 million in 2023, then skyrocketed by 80.78% to -$1.6 million in 2024, then surged by 1403.37% to $21.3 million in 2025.
  • Its last three reported values are $21.3 million in Q3 2025, $14.4 million for Q2 2025, and -$23.6 million during Q1 2025.